Search Results - "Tan, Sabrina C."
-
1
Landscape of Human Immunodeficiency Virus Neutralization Susceptibilities Across Tissue Reservoirs
Published in Clinical infectious diseases (12-10-2022)“…Human immunodeficiency virus type 1 (HIV-1) sequence diversity and the presence of archived epitope muta-tions in antibody binding sites are a major obstacle…”
Get full text
Journal Article -
2
Immunotherapeutics to Treat HIV in the Central Nervous System
Published in Current HIV/AIDS reports (01-10-2020)“…Purpose of Review The application of immunotherapies to HIV presents a new horizon of treatment options, but little is known about what impact they may have on…”
Get full text
Journal Article -
3
Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy
Published in npj vaccines (23-05-2024)“…Mosaic HIV-1 vaccines have been shown to elicit robust humoral and cellular immune responses in people living with HIV-1 (PLWH), that had started…”
Get full text
Journal Article -
4
Increased IL-6 expression precedes reliable viral detection in the rhesus macaque brain during acute SIV infection
Published in JCI insight (22-10-2021)“…Knowledge of immune activation in the brain during acute HIV infection is crucial for the prevention and treatment of HIV-associated neurological disorders. We…”
Get full text
Journal Article -
5
Comparing Urine and Blood Screening Methods to Detect BK Virus After Renal Transplant
Published in Experimental and clinical transplantation (01-02-2021)“…BK polyomavirus can infect healthy individuals; however, in renal transplant recipients, it can cause nephropathy, which can lead to renal allograftfailure…”
Get full text
Journal Article -
6
HIV on the brain: is neurosignalling damage irreversible even on antiretroviral therapy?
Published in AIDS (London) (15-07-2021)Get full text
Journal Article -
7
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
Published in The Lancet (British edition) (10-02-2018)“…A safe, effective, and rapidly scalable vaccine against Zika virus infection is needed. We developed a purified formalin-inactivated Zika virus vaccine (ZPIV)…”
Get full text
Journal Article -
8
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial
Published in Nature medicine (01-06-2022)“…HIV-1 therapy with single or dual broadly neutralizing antibodies (bNAbs) has shown viral escape, indicating that at least a triple bNAb therapy may be needed…”
Get full text
Journal Article -
9
Upregulation of the NKG2D Ligand ULBP2 by JC Polyomavirus Infection Promotes Immune Recognition by Natural Killer Cells
Published in The Journal of infectious diseases (14-06-2024)“…JC polyomavirus (JCPyV) causes progressive multifocal leukoencephalopathy (PML), a potentially fatal complication of severe immune suppression with no…”
Get full text
Journal Article -
10
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial
Published in Nature medicine (01-10-2021)“…Human immunodeficiency virus (HIV)-1-specific broadly neutralizing monoclonal antibodies are currently under development to treat and prevent HIV-1 infection…”
Get full text
Journal Article -
11
Characteristics of Progressive Multifocal Leukoencephalopathy Associated With Sarcoidosis Without Therapeutic Immune Suppression
Published in JAMA neurology (01-06-2023)“…Progressive multifocal leukoencephalopathy can occur in the context of systemic sarcoidosis (S-PML) in the absence of therapeutic immune suppression and can…”
Get more information
Journal Article -
12
Durability of Heterologous and Homologous COVID-19 Vaccine Boosts
Published in JAMA network open (10-08-2022)“…Antibody responses elicited by current messenger RNA (mRNA) COVID-19 vaccines decline rapidly and require repeated boosting. To evaluate the immunogenicity and…”
Get full text
Journal Article -
13
CSF viral escape in a patient with HIV-associated neurocognitive disorder
Published in Journal of neurovirology (01-08-2013)Get full text
Journal Article -
14
Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17–22)
Published in The lancet HIV (01-06-2020)“…Current efficacy studies of a mosaic HIV-1 prophylactic vaccine require four vaccination visits over one year, which is a complex regimen that could prove…”
Get full text
Journal Article -
15
Bridging the gaps between JCV infection models and human disease
Published in Brain (London, England : 1878) (13-11-2024)“…This scientific commentary refers to ‘JC virus spread is potentiated by glial replication and demyelination-linked glial proliferation’ by Li et al…”
Get full text
Journal Article -
16
HIV on the Brain: Is neurosignaling damage irreversible even on ART?
Published in AIDS (London) (15-07-2021)Get full text
Journal Article -
17
Elucidating the role played by the NKG2 family of receptors in natural killer cell responses to JC polyomavirus
Published in The Journal of immunology (1950) (01-05-2023)“…Abstract JC polyomavirus (JCPyV) causes progressive multifocal leukoencephalopathy (PML), a potentially fatal complication of severe immune suppression due to…”
Get full text
Journal Article -
18
Neuroborreliosis: A Case Report on an Unusual Cause of Orbital Inflammation
Published in Infectious diseases in clinical practice (Baltimore, Md.) (01-01-2025)“…Background Neuroborreliosis is involvement of the nervous system in Lyme disease and can often be overlooked as a diagnosis in patients presenting with cranial…”
Get full text
Journal Article -
19
306. Determining natural killer cell responses to JC polyomavirus
Published in Open forum infectious diseases (27-11-2023)“…Abstract Background JC polyomavirus (JCPyV) infects oligodendrocytes and causes progressive multifocal leukoencephalopathy (PML), a potentially fatal…”
Get full text
Journal Article -
20
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate given via standard versus accelerated vaccination schedules: a phase 1, single-center, double-blind, sequential-group, randomized, placebo-controlled clinical trial
Published in The Lancet infectious diseases (06-05-2020)Get full text
Journal Article